Intel sues SoftBank firm over “meritless” patent actions
Intel has filed an antitrust lawsuit against a SoftBank Group-owned investment firm, which allegedly stockpiles “meritless patents” to use in litigation against technology companies.
The complaint, filed on Monday October 21 at the US District Court for the Northern District of California, alleged that “patent assertion entity” (PAE), Fortress Investment Group, has acquired control of more than 1,000 US technology patents.
“Rather than promote the progress of science and useful arts, patent assertion entities aggressively pursue meritless litigation have long been recognised to harm and deter innovation,” the complaint said, claiming that Fortress is a “central player in this emerging strategy”.
Intel said that “by employing a network of PAEs that it either owns or controls, Fortress has created a web of entities that obscures Fortress’s puppeteering role in this scheme”.
It said Fortress makes its money by asserting “weak patents—ie those that never would have been asserted by their former owners—in order to stretch the resources of their targets”, with the hope that targets, like Intel, will resolve the threat posed by Fortress by agreeing to licence the patent.
“Fortress and its PAEs acquire and seek to monetise meritless patents”, Intel added.
Fortress, which was acquired by SoftBank in 2017 for $3.3 billion, allegedly owns and controls a web of PAEs.
Intel said it was filing its lawsuit “to end a campaign of anticompetitive patent aggregation”.
“Fortress has used its stable of PAEs to aggregate a massive portfolio of patents that purportedly read on high-tech consumer and enterprise electronic devices and components or software used to manufacture them,'' the complaint said.
Intel asked the court for damages and to declare all licencing agreements obtained by Fortress, which violate US antitrust laws, as void.
WIPR has approached SoftBank for comment.
Did you enjoy reading this story? Sign up to our free daily newsletters and get stories like this sent straight to your inbox.
Today's top stories:
Shanks v Unilever: £2m Supreme Court ruling paves way for disgruntled inventors
Already registered?
Login to your account
If you don't have a login or your access has expired, you will need to purchase a subscription to gain access to this article, including all our online content.
For more information on individual annual subscriptions for full paid access and corporate subscription options please contact us.
To request a FREE 2-week trial subscription, please signup.
NOTE - this can take up to 48hrs to be approved.
For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk